Pfizer reports patient death in Duchenne gene therapy study
May 7 – A young patient died of cardiac arrest after receiving Pfizer Inc’s experimental gene therapy for a muscle-wasting disease called Duchenne muscular dystrophy, the drugmaker told Reuters on Tuesday. tested in mid-term trials. ultra high definition images “A fatal serious adverse event, cardiac arrest, was reported by a participant in the Phase 2 … Read more